X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (19008) 19008
Book Review (3158) 3158
Publication (1753) 1753
Book / eBook (152) 152
Magazine Article (116) 116
Conference Proceeding (40) 40
Book Chapter (35) 35
Dissertation (11) 11
Trade Publication Article (7) 7
Government Document (3) 3
Web Resource (3) 3
Data Set (2) 2
Paper (2) 2
Presentation (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (17850) 17850
humans (12547) 12547
anti-bacterial agents - therapeutic use (7943) 7943
anti-bacterial agents - pharmacology (7089) 7089
female (5221) 5221
antibiotics (5048) 5048
animals (4778) 4778
male (4509) 4509
microbiology (4353) 4353
microbial sensitivity tests (3313) 3313
anti-bacterial agents - administration & dosage (2993) 2993
adult (2955) 2955
middle aged (2787) 2787
bacteria (2742) 2742
infectious diseases (2704) 2704
biotechnology & applied microbiology (2397) 2397
food science & technology (2362) 2362
aged (2306) 2306
anti-bacterial agents - economics (2291) 2291
analysis (2280) 2280
pharmacology & pharmacy (2124) 2124
research (2046) 2046
drug resistance, bacterial (2013) 2013
infections (1847) 1847
health aspects (1781) 1781
drug resistance (1774) 1774
drug resistance in microorganisms (1774) 1774
adolescent (1648) 1648
treatment outcome (1647) 1647
child (1593) 1593
anti-bacterial agents - chemistry (1530) 1530
risk factors (1455) 1455
antimicrobial resistance (1412) 1412
prevalence (1377) 1377
resistance (1338) 1338
antibacterial agents (1315) 1315
antimicrobial agents (1281) 1281
child, preschool (1267) 1267
abridged index medicus (1248) 1248
retrospective studies (1238) 1238
infection (1231) 1231
escherichia-coli (1206) 1206
food microbiology (1165) 1165
medicine, general & internal (1161) 1161
cattle (1091) 1091
epidemiology (1088) 1088
bacteria - drug effects (1084) 1084
infant (1071) 1071
time factors (1050) 1050
usage (1044) 1044
anti-bacterial agents - adverse effects (1043) 1043
escherichia coli - drug effects (1031) 1031
bacterial infections - drug therapy (1024) 1024
anti-bacterial agents (1019) 1019
aged, 80 and over (1009) 1009
cost-benefit analysis (999) 999
care and treatment (971) 971
escherichia coli (953) 953
hospitals (941) 941
antibiotic resistance (930) 930
management (924) 924
drug resistance, microbial (884) 884
young adult (883) 883
children (874) 874
mortality (870) 870
staphylococcus aureus - drug effects (862) 862
medicine (857) 857
drug therapy (842) 842
prospective studies (833) 833
research article (832) 832
colony count, microbial (831) 831
antibiotic-resistance (829) 829
pathogens (821) 821
studies (814) 814
drug resistance, multiple, bacterial (791) 791
surgery (784) 784
public health (761) 761
therapy (761) 761
veterinary sciences (760) 760
anti-bacterial agents - analysis (757) 757
staphylococcus aureus (757) 757
genes (751) 751
united states (747) 747
antimicrobial activity (715) 715
antibacterial activity (712) 712
pneumonia (710) 710
immunology (704) 704
staphylococcus-aureus (688) 688
physiological aspects (682) 682
dose-response relationship, drug (676) 676
public, environmental & occupational health (669) 669
united-states (656) 656
pediatrics (651) 651
prevention (648) 648
internal medicine (647) 647
food (644) 644
salmonella (639) 639
diagnosis (629) 629
risk-factors (616) 616
identification (607) 607
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (99) 99
UTL at Downsview - May be requested (8) 8
UofT at Scarborough - Stacks (7) 7
Online Resources - Online (5) 5
UofT at Mississauga - Stacks (5) 5
Collection Dvlpm't (Acquisitions) - Vendor file (4) 4
Chemistry (A D Allen) - Stacks (3) 3
St. Michael's College (John M. Kelly) - 2nd Floor (3) 3
Collection Dvlpm't (Acquisitions) - Closed Orders (2) 2
Dentistry (Harry R Abbott) - Withdrawn (2) 2
Earth Sciences (Noranda) - Stacks (2) 2
Baycrest Hospital - Stacks (1) 1
Credit Valley Hospital - Stacks (1) 1
Dentistry (Harry R Abbott) - Stacks (1) 1
Engineering & Comp. Sci. - Stacks (1) 1
Law (Bora Laskin) - Stacks (1) 1
May be requested (1) 1
Providence Healthcare - Stacks (1) 1
Scarborough Hospital - Birchmount (1) 1
Thomas Fisher Rare Book - Rare Book (1) 1
UTL at Downsview - Pharmacy (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (18604) 18604
French (172) 172
Spanish (127) 127
German (91) 91
Russian (82) 82
Dutch (35) 35
Italian (27) 27
Chinese (21) 21
Swedish (19) 19
Japanese (17) 17
Polish (17) 17
Bulgarian (11) 11
Hungarian (11) 11
Portuguese (10) 10
Turkish (9) 9
Czech (8) 8
Norwegian (7) 7
Romanian (6) 6
Danish (5) 5
Hebrew (4) 4
Serbian (4) 4
Croatian (3) 3
Korean (3) 3
Ukrainian (3) 3
Finnish (2) 2
Slovak (2) 2
Lithuanian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Journal Article
European Respiratory Journal, ISSN 0903-1936, 04/2012, Volume 39, Issue 4, pp. 956 - 962
Linezolid is identified as an effective drug with which to treat patients failing multidrug-resistant (MDR)-tuberculosis (TB) treatment. However, cost and... 
Linezolid | Extensively drug-resistant | Multidrug-resistant tuberculosis | SURVIVAL | TBNET | linezolid | METAANALYSIS | EFFICACY | RESPIRATORY SYSTEM | TREATMENT OUTCOMES | TOLERABILITY | multidrug-resistant tuberculosis | XDR-TB | EPIDEMIOLOGY | Drug Costs | Antitubercular Agents - adverse effects | Prospective Studies | Humans | Middle Aged | Male | Oxazolidinones - adverse effects | Oxazolidinones - administration & dosage | Young Adult | Antitubercular Agents - economics | Fluoroquinolones - economics | Acetamides - adverse effects | Adult | Female | Acetamides - economics | Anti-Bacterial Agents - adverse effects | Drug Therapy, Combination | Fluoroquinolones - administration & dosage | Anti-Bacterial Agents - economics | Extensively Drug-Resistant Tuberculosis - drug therapy | Extensively Drug-Resistant Tuberculosis - economics | Anti-Infective Agents - adverse effects | Treatment Outcome | Oxazolidinones - economics | Fluoroquinolones - adverse effects | India | Anti-Infective Agents - administration & dosage | Adolescent | Anti-Infective Agents - economics | Antitubercular Agents - administration & dosage | Anti-Bacterial Agents - administration & dosage | Acetamides - administration & dosage | Drugs | Fluoroquinolones | Levofloxacin | Side effects | Tuberculosis | Sputum | Moxifloxacin | Drug resistance | Capreomycin | Quinolones | Index Medicus
Journal Article
Lancet Infectious Diseases, The, ISSN 1473-3099, 2012, Volume 12, Issue 3, pp. 249 - 253
Journal Article
Annals of Surgery, ISSN 0003-4932, 09/2013, Volume 258, Issue 3, pp. 385 - 391
Journal Article
Journal Article
Journal Article
Health Affairs, ISSN 0278-2715, 2015, Volume 34, Issue 2, pp. 277 - 285
Multidrug-resistant bacterial diseases pose serious and growing threats to human health. While innovation is important to all areas of health research, it is... 
APPROVAL | HEALTH POLICY & SERVICES | INFECTION | FIDAXOMICIN | DRUGS | HEALTH CARE SCIENCES & SERVICES | Orphan Drug Production - legislation & jurisprudence | Drug Industry - trends | United States | Humans | Product Surveillance, Postmarketing - economics | Public Health - economics | Financing, Government - standards | Public-Private Sector Partnerships - economics | Product Surveillance, Postmarketing - standards | Drug Industry - economics | Financing, Government - trends | Anti-Bacterial Agents - adverse effects | Prescription Fees - trends | Clinical Trials as Topic - standards | Drug Industry - standards | Public Health - standards | Reimbursement, Incentive - economics | Anti-Bacterial Agents - economics | Anti-Bacterial Agents - standards | Drug Approval - economics | Reimbursement, Incentive - legislation & jurisprudence | Bacterial Infections - economics | Clinical Trials as Topic - economics | Bacterial Infections - drug therapy | Product Surveillance, Postmarketing - trends | Biomedical Research - trends | Organizational Innovation - economics | International Cooperation | Biomedical Research - economics | Drug Approval - legislation & jurisprudence | Drug Costs - trends | Public-Private Sector Partnerships - trends | Public Health - trends | Orphan Drug Production - economics | Drug Resistance, Multiple, Bacterial - drug effects | Biomedical Research - standards | Reimbursement, Incentive - trends | Studies | Multidrug resistant organisms | Product development | Antibiotics | Pharmaceutical industry | Regulatory reform | Index Medicus
Journal Article